Back to search
FDAFDA · Food and drugs·Recall number D-0299-2015

Benzonatate Capsules, USP, 200 mg, 100-count bottles, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; NDC 68382-248-01, UPC 3 68382 24801 5.

Published December 24, 2014 · Recall initiated: November 26, 2014

Summary

FDA records drug Class II recall D-0299-2015, published December 24, 2014 and initiated November 26, 2014. Recalling firm: Zydus Pharmaceuticals USA Inc; Status: Terminated; Reported quantity: 58,920 bottles; Lot: Lot #: MP2137, MP2138, MP2139, Exp 01/16; MP3614, Exp 03/16; MP5611, MP5613, Exp 05/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Zydus Pharmaceuticals USA Inc
Distributor
Nationwide and Puerto Rico
Lot
Lot #: MP2137, MP2138, MP2139, Exp 01/16; MP3614, Exp 03/16; MP5611, MP5613, Exp 05/16
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Benzonatate Capsules, USP, 200 mg, 100-count bottles, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; NDC 68382-248-01, UPC 3 68382 24801 5. recalled?

Yes. FDA published recall D-0299-2015 on December 24, 2014. Reported hazard: Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.

What should I do if I have this product?

Voluntary: Firm initiated · Letter